Phase II clinical study of the safety and efficacy of sintilimab in combination with axitinib and stereotactic radiotherapy in the treatment of local-regional recurrent renal cell cancer.

被引：0
|
作者：
Liu, Ruiqi
Liu, Yang
Zhang, Zhiling
Gao, Jianming
Zhang, Xinyue
Pan, Qiwen
Li, Yilin
Cai, Lingling
Guo, Shengjie
Han, Hui
Zhou, Fangjian
Dong, Pei
He, Liru
机构：
[1] Sun Yat Sen Univ, Dept Radiat Oncol, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Dept Urol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Urol, Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16511
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of axitinib in combination with sintilimab as neoadjuvant therapy for patients with locally advanced renal cell carcinoma: A phase II clinical study
    Huang, Yixin
    Zhang, Zhiling
    Zou, Xiangpeng
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Mid -Term Analysis of the Combination Therapy of Axitinib, Toripalimab, and Stereotactic Ablative Body Radiotherapy (SABR) in the Treatment of Recurrent Metastatic Renal Cell Carcinoma
    Hu, K.
    Ma, M. W.
    Gao, X. S.
    Chen, J. Y.
    Li, X. Y.
    Qin, S. B.
    Ren, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E538 - E538
  • [3] Salvage guideline for local-regional failure after stereotactic ablative radiotherapy for early-stage non-small cell lung cancer.
    Brooks, Eric
    Sun, Bing
    Zhao, Lina
    Komaki, Ritsuko
    Liao, Zhongxing X.
    Jeter, Melenda
    O'Reilly, Michael
    Welsh, James William
    Gomez, Daniel Richard
    Nguyen, Quynh
    Antonoff, Mara
    Hahn, Stephen M.
    Heyrnach, John
    Rice, David C.
    Chang, Joe Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] PHASE II, MULTI-CENTER STUDY OF SINTILIMAB IN COMBINATION WITH AXITINIB IN PATIENTS WITH ADVANCED FUMARATE HYDRATASE-DEFICIENT RENAL CELL CARCINOMA
    Zhang, Xingming
    Liu, Haoyang
    Zhang, Yaowen
    Zhao, Junjie
    Chen, Yuntian
    Zeng, Yuhao
    Wang, Zilin
    Sun, Guangxi
    Liang, Jiayu
    Zhu, Sha
    Zhao, Jinge
    Zheng, Linmao
    Yin, Xiaoxue
    Chen, Junru
    Hu, Xu
    Sheng, Xinan
    Wang, Yongquan
    Gong, Kan
    Liu, Xiaodong
    Huang, Rui
    Wei, Qiang
    Li, Xiang
    Liu, Jiyan
    Shen, Pengfei
    Chen, Ni
    Yao, Jin
    Liu, Zhenhua
    Zeng, Hao
    JOURNAL OF UROLOGY, 2023, 209 : E726 - E726
  • [5] Phase II multi-center study of sintilimab in combination with axitinib in patients with advanced fumarate hydratase-deficient renal cell carcinoma.
    Zhang, Xingming
    Liu, Haoyang
    Zhang, Yaowen
    Zhao, Junjie
    Chen, Yuntian
    Sun, Guangxi
    Sheng, Xinan
    Wang, Yongquan
    Gong, Kan
    Liu, Xiaodong
    Huang, Rui
    Wei, Qiang
    Li, Xiang
    Liu, Jiyan
    Shen, Pengfei
    Chen, Ni
    Yao, Jin
    Liu, Zhenhua
    Zeng, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [6] Phase II clinical study evaluating the efficacy and safety of disitamab vedotin combined with sintilimab and S-1 in the conversion treatment of HER2-overexpression unresectable gastric cancer.
    Liang, Han
    Wang, Xiaona
    Shang, Liang
    Chen, Xiaodong
    Cheng, Xiangdong
    Li, Ziyu
    Wei, Bo
    Zheng, Zhichao
    Li, Guoxin
    Ji, Gang
    Zhang, Zizhen
    Tian, Yantao
    Zhao, Qun
    Yang, Lin
    Liu, Heli
    Chen, Hao
    Liu, Yanliang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS428 - TPS428
  • [7] Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study
    Rixe, Olivier
    Bukowski, Ronald M.
    Michaelson, M. Dror
    Wilding, George
    Hudes, Gaty R.
    Bolte, Oliver
    Motzer, Robert J.
    Bycott, Paul
    Liou, Katherine F.
    Freddo, James
    Trask, Peter C.
    Kim, Sinil
    Rini, Brian I.
    LANCET ONCOLOGY, 2007, 8 (11): : 975 - 984
  • [8] Efficacy and safety of tislelizumab plus axitinib in the treatment of locally advanced clear cell renal cell carcinoma: A single center clinical study
    Ji, C.
    Yang, W.
    Zhang, S.
    Liu, G.
    Chen, Y.
    Cao, Y.
    Guo, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1524 - S1524
  • [9] Efficacy and safety of sintilimab in combination with chemotherapy for recurrent extensive-stage small cell lung cancer: a real-world retrospective study
    Wang, Jingyi
    Liang, Shuzhi
    Xu, Li
    Kong, Yi
    Seki, Nobuhiko
    Ganti, Apar Kishor
    Neal, Joel W.
    Li, Jia
    Xu, Fang
    Li, Kang
    Xu, Yan
    Wu, Lin
    Chen, Bolin
    JOURNAL OF THORACIC DISEASE, 2024, 16 (06) : 3897 - 3908
  • [10] Paclitaxel in combination with cisplatin, etoposide and thoracic radiotherapy for limited small cell lung cancer. A Phase II study
    Bremnes, RM
    Sundstrom, S
    Vilsvik, J
    Aasebo, U
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S253 - S254
12345